These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10493177)

  • 1. Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation.
    Bothwell AL
    Immunol Res; 1999; 19(2-3):233-43. PubMed ID: 10493177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
    Fodor WL; Williams BL; Matis LA; Madri JA; Rollins SA; Knight JW; Velander W; Squinto SP
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11153-7. PubMed ID: 7526391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD86 blockade in genetically modified porcine cells delays xenograft rejection by inhibiting T-cell and NK-cell activation.
    Costa C; Pizzolato MC; Shen Y; Wang Y; Fodor WL
    Cell Transplant; 2004; 13(1):75-87. PubMed ID: 15040608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenotransplantation.
    Cozzi E; White DJ
    Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):514-8. PubMed ID: 8978999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
    Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
    Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
    Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
    Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
    Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
    Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
    Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
    Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenotransplantation: where are we in 2008?
    Sprangers B; Waer M; Billiau AD
    Kidney Int; 2008 Jul; 74(1):14-21. PubMed ID: 18418354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of xenotransplant rejection].
    Candinas D; Seebach JD
    Zentralbl Chir; 1999; 124(7):591-9. PubMed ID: 10474871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are pigs transgenic for human complement regulatory proteins necessary for xenotransplantation?
    Loveland BE; Cooper DK; Sandrin MS
    Transplantation; 2000 Aug; 70(4):567-8. PubMed ID: 10972209
    [No Abstract]   [Full Text] [Related]  

  • 14. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness.
    Kirk AD; Li RA; Kinch MS; Abernethy KA; Doyle C; Bollinger RR
    Transplantation; 1993 Apr; 55(4):924-31. PubMed ID: 8475569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in xenotransplantation.
    Cozzi E; Masroor S; Soin B; Vial C; White DJ
    Clin Nephrol; 2000 Apr; 53(4):suppl 13-8. PubMed ID: 10809429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenotransplantation: problems and prospects.
    Bach FH
    Annu Rev Med; 1998; 49():301-10. PubMed ID: 9509265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell-mediated immunological barriers to xenotransplantation.
    Scalea J; Hanecamp I; Robson SC; Yamada K
    Xenotransplantation; 2012; 19(1):23-30. PubMed ID: 22360750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of xenotransplantation.
    Saadi S; Platt JL
    Life Sci; 1998; 62(5):365-87. PubMed ID: 9449228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modification of alphaGal expression in xenogeneic endothelial cells yields a complex immunological response.
    Fischbeck JA; Baier JM; Akella R; Hern-Anderson D; Schmidt CE
    Tissue Eng; 2001 Dec; 7(6):743-56. PubMed ID: 11749731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.